TXG as of Nov 1 · 08:19 ET
TXGNasdaqLaboratory Analytical Instruments

10x Genomics, Inc. · Brief

Next report

4 days

Nov 5 · after closeconfirmedQ3 FY26

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±15.8%
avg realized
±6.0%
Feb 12 '25±13.0%▼−0.50%×0.04
May 8 '25±16.3%▲+1.62%×0.10
Aug 7 '25±12.3%▼−3.98%×0.32
Q3 FY25±25.4%▲+17.31%×0.68
Jan 12 '26±11.3%▼−3.23%×0.29
Feb 12 '26±19.1%▲+3.48%×0.18
Q1 FY26±14.4%▼−3.66%×0.25
Q2 FY26±14.8%▲+14.10%×0.96
quarterimplied−30%0+30%realized×
Q2 FY26±14.8%▲+14.10%×0.96
Q1 FY26±14.4%▼−3.66%×0.25
Feb '26±19.1%▲+3.48%×0.18
Jan '26±11.3%▼−3.23%×0.29
Q3 FY25±25.4%▲+17.31%×0.68
Aug '25±12.3%▼−3.98%×0.32
2 older reports
May '25±16.3%▲+1.62%×0.10
Feb '25±13.0%▼−0.50%×0.04
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · confirmed

Bull2 of 4

4disclosed supplier and customer ties in SEC filingsSEC filings
391managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

8 of 8recent reports where the move came in under the options implied rangeEarnings history
29managers whose positions together make up four fifths of reported value13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

TXG report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 30unusualUnusual volume: ×2.27 RVOL at 10:31 ET.Source
Oct 22impliedImplied move: ±18.8% into Nov 5 earnings (Oct 22 close).Source
Oct 13report dateEarnings date confirmed: Nov 5, after close.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.